Frélii, Inc. (FRLI)
Lehi, NV, US
Frélii, Inc. specializes in delivering personalized, subscription-based health and wellness programs. Through its frelii.com web platform, the company designs individual health assessments and tailored nutrition plans. These plans are meticulously developed by analyzing a comprehensive range of personal data, including genetic information, physiological markers, environmental influences, lifestyle choices, and diagnostic lab results. Additionally, the platform facilitates access to various related health products, such as diagnostic testing kits, custom-compounded pharmacy items, and a selection of nutritional and vitamin supplements. Formerly operating as Vican Resources, Inc., the organization rebranded to Frélii, Inc. in March 2018. The company maintains its headquarters in Lehi, Utah.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +9,900.00% | -90.00% | -99.95% | -100.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Software - Application: +13.0%— Q3'19: +76.3% (vs Q3'18)
-
EPS growth Software - Application: +28.6%-344.5% Q3'19: +5.8% (vs Q3'18)
-
FCF margin FCF growth · Software - Application: +45.3%-14,774.1% Q3'19: -1,367.5% (vs Q3'18)
-
EBIT margin Software - Application: +9.4%-15,432.2% Q3'19: -10,513.0% (vs Q3'18)
-
ROIC Software - Application: +7.5%-3,247.2% Q3'19: -740.2% (vs Q3'18)
-
Share dilution Software - Application: +0.0%+281.2% Q3'19: +16.7% (vs Q3'18)
-
Debt / EBITDA Net debt/EBITDA · Software - Application: -1.16×0.00× Q3'19: -0.02× (vs Q3'18)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Owner Earnings
Ownership Overview
Ownership breakdown not available.
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Cumbria Capital, L.P. | 85.86M | 88.80% | 85.86M | — | 85.86M | 10.00 | CO | Texas | 2009-08-17 | ↗ |
| 2 | Cyrus Boga | 85.86M | 88.80% | 85.86M | — | 85.86M | 10.00 | IN | United States | 2009-08-17 | ↗ |
| 3 | Boga | 73.73M | 75.66% | 73.73M | — | 73.73M | 10.00 | IN | States | 2010-02-26 | ↗ |
| 4 | Capital, L.P. | 73.73M | 75.66% | 73.73M | — | 73.73M | 10.00 | PN | Texas | 2010-02-26 | ↗ |
| 5 | 6961916 CANADA INC. | 25.00M | 37.97% | 25.00M | — | 25.00M | — | CO | Canada | 2011-06-03 | ↗ |
| 6 | Lorne Kalisky | 25.00M | 37.97% | — | 25.00M | — | — | IN | Canada | 2011-06-03 | ↗ |
| 7 | Mark Klok | 25.00M | 37.97% | — | 25.00M | — | — | IN | Canada | 2011-06-03 | ↗ |
| 8 | Sierra Vista Holdings, Inc. | 25.00M | 37.97% | 25.00M | — | 25.00M | — | CO | Canada | 2011-06-03 | ↗ |
| 9 | Amit J. Sanghvi | 7.60M | 7.80% | 7.60M | — | 7.60M | — | IN | United States of America | 2010-03-26 | ↗ |
| 10 | CHRISTOPHER DEAN | 7.50M | 21.21% | — | — | — | — | IN | — | 2018-02-23 | ↗ |
| 11 | GREGORY MONGEON | 7.50M | 21.21% | — | — | — | — | IN | — | 2018-02-23 | ↗ |
| 12 | Chene C. Gardner | 5.00M | 5.56% | — | 5.00M | — | — | IN | United States of America | 2011-05-06 | ↗ |
| 13 | Chene C. Gardner and Associates, Inc. | 5.00M | 5.56% | 5.00M | — | 5.00M | — | IN | United States of America | 2011-05-06 | ↗ |
| 14 | Craig Olivas | 5.00M | 5.56% | — | 5.00M | — | — | IN | United States of America | 2011-05-09 | ↗ |
| 15 | Five Star IR, Inc. | 5.00M | 5.56% | 5.00M | — | 5.00M | — | IN | United States of America | 2011-05-09 | ↗ |
| 16 | Kenneth I. Denos | 5.00M | 5.56% | — | 5.00M | — | — | IN | United States of America | 2011-05-06 | ↗ |
| 17 | Kenneth I. Denos, P.C. | 5.00M | 5.56% | 5.00M | — | 5.00M | — | IN | United States of America | 2011-05-06 | ↗ |
| 18 | Pamela Ruppert | 5.00M | 5.56% | 5.00M | — | 5.00M | — | IN | United States of America | 2011-05-09 | ↗ |
| 19 | BARCLAYS GLOBAL INVESTORS, NA. | 1.15M | 3.52% | 131.3K | — | 131.3K | — | BK | Delaware | 2014-02-13 | ↗ |
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-02-02 | Mongeon Gregory John | Director / Officer / 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 7,500,000 | — | ↗ |
| 2018-02-02 | Kline Julia Dellaccio | Officer | — | D | Common Stock | 0 | 0.00 | — | 1,000,000 | — | ↗ |
| 2018-02-02 | Jones Seth Charles | Officer | — | D | Common Stock | 0 | 0.00 | — | 1,450,000 | — | ↗ |
| 2018-02-02 | Jenkins Ian Geran | Director / Officer / 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 7,500,000 | — | ↗ |
| 2018-02-02 | Dean Christopher Wayne | Director / Officer / 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 7,500,000 | — | ↗ |
| 2017-04-05 | Jenkins Ian Geran | Officer / 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 1,830,000 | — | ↗ |
| 2011-12-20 | Med Ex Direct, Inc. | 10% Owner | — | D | Series B Preferred Stock | 0 | 0.00 | — | 8,750,000 | — | ↗ |
| 2011-12-20 | Hammonds Kristina | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2011-12-20 | Denos Kenneth I | Director / 10% Owner | — | I | Series C Preferred Shares | 0 | 0.00 | — | 800,000 | — | ↗ |
| 2011-12-20 | Boga Cyrus | Director | F-InKind | A | Series C Preferred Stock | 600,000 | 0.01 | 6.0K | 0 | — | ↗ |
| 2011-12-15 | Boga Cyrus | Director | — | I | Series C Preferred Shares | 0 | 0.00 | — | 0 | — | ↗ |
| 2011-05-26 | Safran Corey | Officer | — | D | Common Shares | 0 | 0.00 | — | 0 | — | ↗ |
| 2011-05-26 | Kalisky Lorne | Director / Officer / 10% Owner | — | I | Series B Preferred Shares (on an as-converted basis) | 0 | 0.00 | — | 30,000,000 | — | ↗ |
| 2011-05-26 | Gardner Chene | Officer | — | I | Common Stock | 0 | 0.00 | — | 5,000,000 | — | ↗ |
| 2011-05-26 | Chene Gardner & Associates Inc. | — | — | D | Common Stock | 0 | 0.00 | — | 5,000,000 | — | ↗ |
| 2011-05-26 | 6961916 CANADA INC. | 10% Owner | — | D | Series B Preferred Shares (on an as-converted basis) | 0 | 0.00 | — | 30,000,000 | — | ↗ |
| 2011-04-28 | Thomas John Darrow | Director / Officer / 10% Owner | P-Purchase | A | common shares | 225,000 | 0.01 | 1.7K | 225,000 | — | ↗ |
| 2011-04-28 | Sierra Vista Holdings, Inc. | 10% Owner | P-Purchase | A | common shares | 25,000,000 | 0.01 | 187.5K | 25,000,000 | — | ↗ |
| 2011-04-28 | KLOK MARK DANIEL | Director / 10% Owner | P-Purchase | A | common shares | 25,000,000 | 0.01 | 187.5K | 25,000,000 | — | ↗ |
| 2011-04-19 | Sierra Vista Holdings, Inc. | 10% Owner | — | I | Series A Preferred Stock | 0 | 0.00 | — | 100,000 | — | ↗ |
| 2011-04-19 | KLOK MARK DANIEL | 10% Owner | — | I | Series A Preferred Stock | 0 | 0.00 | — | 100,000 | — | ↗ |
| 2011-04-19 | CUMBRIA CAPITAL LP | 10% Owner | S-Sale | D | Series A Preferred Stock | 100,000 | 3.50 | 350.0K | 0 | — | ↗ |
| 2011-04-19 | Boga Cyrus | Director / Officer / 10% Owner | S-Sale | D | Series A Preferred Stock | 100,000 | 3.50 | 350.0K | 0 | — | ↗ |
| 2011-04-15 | CUMBRIA CAPITAL LP | 10% Owner | S-Sale | D | Common Stock | 70,798,500 | 0.02 | 1.06M | 46,666,667 | — | ↗ |
| 2011-04-15 | Boga Cyrus | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 70,798,500 | 0.02 | 1.06M | 46,666,667 | — | ↗ |
| 2010-03-08 | Gordon Robert Duff | — | S-Sale | D | Common Stock | 5,735,000 | 0.01 | 63.1K | 0 | — | ↗ |
| 2010-02-25 | CUMBRIA CAPITAL LP | 10% Owner | S-Sale | D | Tremont Fair, Inc. | 11,136,000 | 0.02 | 222.7K | 73,726,500 | — | ↗ |
| 2010-02-25 | Boga Cyrus | Director / Officer / 10% Owner | S-Sale | D | Tremont Fair, Inc. | 11,136,000 | 0.02 | 222.7K | 73,726,500 | — | ↗ |
| 2010-02-24 | Thomas John Darrow | Director | S-Sale | A | Tremont Fair, Inc. | 83,333 | 0.01 | 833.33 | 120,371 | — | ↗ |
| 2010-02-24 | Condon Rob | Director | S-Sale | A | Tremont Fair, Inc. | 83,333 | 0.01 | 833.33 | 2,083,333 | — | ↗ |
| 2010-02-08 | CUMBRIA CAPITAL LP | 10% Owner | S-Sale | D | Tremont Fair, Inc. | 1,000,000 | 0.02 | 20.0K | 84,862,500 | — | ↗ |
| 2010-02-08 | Boga Cyrus | Director / Officer / 10% Owner | S-Sale | D | Tremont Fair, Inc. | 1,000,000 | 0.02 | 20.0K | 84,862,500 | — | ↗ |
| 2009-07-31 | CUMBRIA CAPITAL LP | 10% Owner | J-Other | A | Cancer Detection Corporation | 80,000,000 | 0.06 | 4.80M | 8,750,000 | — | ↗ |
| 2009-07-31 | Boga Cyrus | Director / Officer | J-Other | A | Cancer Detection Corporation | 80,000,000 | 0.06 | 4.80M | 83,750,000 | — | ↗ |
| 2008-10-31 | Gordon Robert Duff | Director / 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 5,926,239 | — | ↗ |
| 2008-10-20 | CUMBRIA CAPITAL LP | — | — | D | Common Stock | 0 | 0.00 | — | 3,750,000 | — | ↗ |
| 2008-10-20 | Boga Cyrus | Director | — | I | Common Stock | 0 | 0.00 | — | 3,750,000 | — | ↗ |
| 2005-01-17 | Lamkin Aaron | — | — | I | Common Stock | 0 | 0.00 | — | 1,050,000 | — | ↗ |
| 2005-01-17 | Bayview Management LLC | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 1,050,000 | — | ↗ |
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Seth Charles Jones | Chief Marketing Officer | 52.5K | male |
| Ian Geran Jenkins | President, Chief Executive Officer, Chief Financial Officer & Director | 52.0K | male |
| Hans Jenkins | Chief Medical Officer & Director | — | — |
| Jayson Uffens | Chief Technology Officer & Director | — | male |
| Sandeep Uppal | Chief Administrative Officer | — | male |
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for FRLI
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
